百万退伍军人计划中的青光眼遗传风险评分
该横断面研究在百万退伍军人计划(MVP)中评估了127个变异位点组成的遗传风险评分(GRS)对原发性开角型青光眼(POAG)风险分层及侵入性青光眼手术(IGS)记录的关联。研究纳入5830例POAG病例和64476例对照,结果显示GRS在EUR和AFR退伍军人中均与POAG显著相关(P < 5 × 10-5),但EUR中位于最高GRS十分位的比例高于AFR(21.9%-23.6% vs 12.9%-14.5%)。在AFR病例中,仅基于祖先特异性效应估计的加权GRS与IGS记录相关;在EUR病例中,所有类型GRS均与IGS相关。
要点
- 在MVP的EUR和AFR退伍军人中,127变异GRS均与POAG显著相关(P < 5 × 10-5)。
- EUR中位于最高GRS十分位的比例高于AFR(21.9%-23.6% vs 12.9%-14.5%)。
- AFR病例中仅祖先特异性加权GRS与IGS记录相关,EUR病例中所有GRS类型均与IGS相关。
核心结论
- GRS在EUR和AFR退伍军人中对POAG风险分层及IGS关联的表现存在差异,这凸显了POAG复杂的风险架构、基因组学研究多样代表性的重要性,以及扩展多样性POAG基因组数据的必要性,以使GRS能公平地帮助筛查高POAG风险且可能需要更积极治疗的个体。
研究设计与样本
- 横断面研究,纳入MVP中具有插补遗传数据的退伍军人,包括5830例POAG病例(其中445例电子健康记录中有IGS记录)和64476例对照。
- 在EUR(3382例病例和58811例对照)和AFR(2448例病例和5665例对照)退伍军人中测试了127个已发表风险变异的未加权和加权GRS;加权GRS使用最近发表的跨祖先和祖先特异性荟萃分析报告中的效应估计计算。
主要发现
- GRS在两组中均与POAG显著相关(P < 5 × 10-5)。
- EUR中位于最高GRS十分位的比例 consistently 为21.9%-23.6%,AFR为12.9%-14.5%。
- 在AFR病例中,仅基于祖先特异性效应估计的加权GRS与IGS记录相关;在EUR病例中,所有GRS类型均与IGS相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Primary open-angle glaucoma (POAG) is a degenerative eye disease for which early treatment is critical to mitigate visual impairment and irreversible blindness. POAG-associated loci individually confer incremental risk. Genetic risk score(s) (GRS) could enable POAG risk stratification. Despite significantly higher POAG burden among individuals of African ancestry (AFR), GRS are limited in this population. A recent large-scale, multi-ancestry meta-analysis identified 127 POAG-associated loci and calculated cross-ancestry and ancestry-specific effect estimates, including in European ancestry (EUR) and AFR individuals. We assessed the utility of the 127-variant GRS for POAG risk stratification in EUR and AFR Veterans in the Million Veteran Program (MVP). We also explored the association between GRS and documented invasive glaucoma surgery (IGS). DESIGN: Cross-sectional study. PARTICIPANTS: MVP Veterans with imputed genetic data, including 5830 POAG cases (445 with IGS documented in the electronic health record) and 64 476 controls. METHODS: We tested unweighted and weighted GRS of 127 published risk variants in EUR (3382 cases and 58 811 controls) and AFR (2448 cases and 5665 controls) Veterans in the MVP. Weighted GRS were calculated using effect estimates from the most recently published report of cross-ancestry and ancestry-specific meta-analyses. We also evaluated GRS in POAG cases with documented IGS. MAIN OUTCOME MEASURES: Performance of 127-variant GRS in EUR and AFR Veterans for POAG risk stratification and association with documented IGS. RESULTS: GRS were significantly associated with POAG (P < 5 × 10-5) in both groups; a higher proportion of EUR compared with AFR were consistently categorized in the top GRS decile (21.9%-23.6% and 12.9%-14.5%, respectively). Only GRS weighted by ancestry-specific effect estimates were associated with IGS documentation in AFR cases; all GRS types were associated with IGS in EUR cases. CONCLUSIONS: Varied performance of the GRS for POAG risk stratification and documented IGS association in EUR and AFR Veterans highlights (1) the complex risk architecture of POAG, (2) the importance of diverse representation in genomics studies that inform GRS construction and evaluation, and (3) the necessity of expanding diverse POAG-related genomic data so that GRS can equitably aid in screening individuals at high risk of POAG and who may require more aggressive treatment.
引用
- Waksmunski AR, Kinzy TG, Cruz LA, et al. Glaucoma Genetic Risk Scores in the Million Veteran Program. Ophthalmology. 2022. PMID: 35718050. doi:10.1016/j.ophtha.2022.06.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。